Acetylcysteine 200 MG/ML Inhalation Solution — RxCUI 307719
RxNorm drug concept · Semantic clinical drug
RxCUI 307719
Semantic clinical drug · SCD
● Current RxNorm concept 21 FDA products
21 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI307719
Official nameAcetylcysteine 200 MG/ML Inhalation Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asacetylcysteine 20 % Inhalation Solution
FDA products mapped21
Package NDCs mapped21
Reported Medicaid activity (SDUD)15,323 prescriptions · 34 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Acetylcysteine Oral Inhalation: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- When you inhale it as a mist through a nebulizer, acetylcysteine works right where you need it — directly in your airways. It breaks down the chemical bonds that make mucus thick a...
- What exactly does acetylcysteine inhalation do — and why do I need to inhale it instead of just taking a pill?
- That depends on your condition and what your prescriber decides is right for you — it can vary quite a bit. In general, it's used several times a day. Follow the schedule your prov...
- How often will I need to use the nebulizer?
🕸️ Concept Web — How Acetylcysteine 200 MG/ML Inhalation Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Acetylcysteine 200 MG/ML Inhalation Solution
RxCUI 307719 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Acetylcysteine
197IN
-
Acetylcysteine
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Acetylcysteine Inhalation Solution
2108211SCDF -
Acetylcysteine Inhalant Product
1153148SCDG -
Inhalation Solution
346161DF -
Inhalant Product
1151123DFG
-
Acetylcysteine Inhalation Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Acetylcysteine 200 MG/ML
340088SCDC
-
Acetylcysteine 200 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Acetylcysteine 200 MG/ML
SCDC · 340088 -
Acetylcysteine Inhalation Solution
SCDF · 2108211 -
Acetylcysteine Inhalant Product
SCDG · 1153148
📦 FDA Products & Package NDCs
21 products · 21 package NDCs
21 package NDCs map to RxCUI 307719 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00409-3307-03 | 3 VIAL in 1 CARTON (0409-3307-03) / 30 mL in 1 VIAL (0409-3... | Acetylcysteine | Hospira, Inc. | 2005-04-30 |
| 00409-3308-03 | 3 VIAL in 1 CARTON (0409-3308-03) / 30 mL in 1 VIAL (0409-3... | Acetylcysteine | Hospira, Inc. | 2005-06-01 |
| 00517-7504-25 | 25 VIAL, GLASS in 1 TRAY (0517-7504-25) / 4 mL in 1 VIAL, G... | Acetylcysteine | American Regent, Inc. | 1995-10-01 |
| 00517-7510-03 | 3 VIAL, GLASS in 1 BOX (0517-7510-03) / 10 mL in 1 VIAL, GL... | Acetylcysteine | American Regent, Inc. | 1995-10-01 |
| 00517-7604-25 | 25 VIAL, GLASS in 1 TRAY (0517-7604-25) / 4 mL in 1 VIAL, G... | Acetylcysteine | American Regent, Inc. | 1995-10-01 |
| 00517-7610-03 | 3 VIAL, GLASS in 1 BOX (0517-7610-03) / 10 mL in 1 VIAL, GL... | Acetylcysteine | American Regent, Inc. | 1995-10-01 |
| 42494-0435-25 | 25 VIAL in 1 CARTON (42494-435-25) / 4 mL in 1 VIAL | Acetylcysteine | Cameron Pharmaceuticals | 2025-08-21 |
| 42494-0436-25 | 25 VIAL in 1 CARTON (42494-436-25) / 4 mL in 1 VIAL | Acetylcysteine | Cameron Pharmaceuticals | 2025-08-21 |
| 55154-5730-05 | 5 VIAL, GLASS in 1 BAG (55154-5730-5) / 4 mL in 1 VIAL, GLA... | Acetylcysteine | Cardinal Health 107, LLC | 2011-05-06 |
| 55154-5731-05 | 5 VIAL, GLASS in 1 BAG (55154-5731-5) / 4 mL in 1 VIAL, GLA... | Acetylcysteine | Cardinal Health 107, LLC | 2011-05-06 |
| 63323-0690-30 | 3 VIAL in 1 CARTON (63323-690-30) / 30 mL in 1 VIAL (63323-... | Acetylcysteine | Fresenius Kabi USA, LLC | 2012-09-01 |
| 63323-0690-44 | 3 VIAL in 1 CARTON (63323-690-44) / 30 mL in 1 VIAL (63323-... | Acetylcysteine | Fresenius Kabi USA, LLC | 2012-09-01 |
| 63323-0691-30 | 3 VIAL in 1 CARTON (63323-691-30) / 30 mL in 1 VIAL (63323-... | Acetylcysteine | Fresenius Kabi USA, LLC | 2014-03-31 |
| 63323-0692-10 | 3 VIAL in 1 CARTON (63323-692-10) / 10 mL in 1 VIAL (63323-... | Acetylcysteine | Fresenius Kabi USA, LLC | 2012-09-01 |
| 63323-0693-10 | 3 VIAL in 1 CARTON (63323-693-10) / 10 mL in 1 VIAL (63323-... | Acetylcysteine | Fresenius Kabi USA, LLC | 2014-03-31 |
| 63323-0694-04 | 25 VIAL in 1 CARTON (63323-694-04) / 4 mL in 1 VIAL (63323-... | Acetylcysteine | Fresenius Kabi USA, LLC | 2012-09-01 |
| 63323-0694-44 | 25 VIAL in 1 CARTON (63323-694-44) / 4 mL in 1 VIAL (63323-... | Acetylcysteine | Fresenius Kabi USA, LLC | 2012-09-01 |
| 63323-0695-04 | 25 VIAL in 1 CARTON (63323-695-04) / 4 mL in 1 VIAL (63323-... | Acetylcysteine | Fresenius Kabi USA, LLC | 2014-03-31 |
| 70069-0018-25 | 25 VIAL in 1 CARTON (70069-018-25) / 4 mL in 1 VIAL (70069-... | Acetylcysteine | Somerset Therapeutics, LLC | 2025-03-04 |
| 70069-0019-25 | 25 VIAL in 1 CARTON (70069-019-25) / 4 mL in 1 VIAL (70069-... | Acetylcysteine | Somerset Therapeutics, LLC | 2025-03-04 |
| 70069-0020-03 | 3 VIAL in 1 CARTON (70069-020-03) / 30 mL in 1 VIAL (70069-... | Acetylcysteine | Somerset Therapeutics, LLC | 2025-03-04 |
Observed labelers:
Fresenius Kabi USA, LLC (8) ·
American Regent, Inc. (4) ·
Somerset Therapeutics, LLC (3) ·
Cameron Pharmaceuticals (2) ·
Cardinal Health 107, LLC (2) ·
Hospira, Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J7608 | Acetylcysteine non-comp unit | 17 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.